| http://www.w3.org/ns/prov#value | - exemastane), antiangiogenic proteins, small molecules, gene therapies or other agents that inhibit angiogenesis or vascularization of tumors (e.g., meth-1, meth-2 and thalidomide), bevacizumab (available as AVASTIN??? from Genentech), squalamine, endostatin, angiostatin, ANGIOZYME??? from Ribozyme Pharmaceuticals, neovastat (available as AE-941??? from Aeterna Zentaris), CC-5013 (available as REVI
|
